Steve Hahn of FDA is still in charge of approval of drugs. With vaccines, FDA used independent bodies for approval.
The National Institutes of Health announced an initiative Friday to unify disparate efforts across the drug industry to respond to the coronavirus-related pandemic.
Pharmaceutical companies will collaborate across hundreds of COVID-19 clinical trials, the NIH says, by sharing “master protocols” on how those clinical trials will work.
"Collaboration is a critical ingredient for success and the FDA will continue to use every tool possible under our Coronavirus Treatment Acceleration Program to speed the development of safe and effective medical countermeasures," said Food and Drug Administration Commissioner Stephen Hahn in a statement.